PATENT CLAIM ANALYSIS

Application Number: 16086701
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["424", "205100"]

Abstract:
The present invention pertains to a vaccine comprising in combination non-replicating immunogen of porcine circo virus type 2 and live attenuated PRRS virus for use in prophylactically treating an animal against an infection with porcine circovirus type 2 (PCV2) and an infection with PRRS virus by administration of the vaccine into the dermis of the animal.

Claim (Index 14):
A vaccine of  claim 11 , wherein the non-replicating immunogen of PCV2 is recombinantly expressed ORF2 protein of PCV2.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.43902
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15038765', '15100880', '14755771', '15885113', '12137184']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7552373680722241
- 35 USC 102 Novelty (BERT): 0.5623317681021296
- Combined Prediction Score: 0.7359468080752147
- Mean Citation Score: 392.623234
- Max Citation Score: 451.01007
- Similarity Product: 364.52467307340856

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test